unknown
Stage
1
Investors
About
Intervacc is a Swedish biotechnology company that develops recombinant protein-based vaccines and pharmaceuticals for animal health, focusing on improving animal welfare and protecting against bacterial infections.
Explore Intervacc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.